Ashland Inc. (ASH)
NYSE · Basic Materials · Specialty Chemicals
$68.78−1.06%as of Oct 6, 2026, 1:35 AM ET
- Market cap
- $3.1B
- P/E (trailing)
- 44.1
- Forward P/E
- 16.0
- Dividend yield
- 2.4%
- 52-week range
- $47.12 – $78.25
- 52-week change
- +46.39%
- EPS (trailing)
- $1.56
- Analyst rating
- 1.6 Buy
- Next earnings
- Nov 3, 2026
Fiscal year to Sep 2025
- Revenue
- $1.8B (−13.68%)
- Operating margin
- −42.5%
- Diluted EPS
- −$18.23
From the company’s annual report on SEC EDGAR.
About Ashland Inc.
Ashland Inc. provides additives and specialty ingredients in the North and Latin America, Europe, Asia Pacific, and internationally. It operates through Life Sciences, Personal Care, Specialty Additives, and Intermediates segments. The Life Sciences segment offers pharmaceutical solutions, including controlled release polymers, disintegrants, tablet coatings, thickeners, solubilizers, and tablet binders; and nutrition solutions, such as thickeners, stabilizers, emulsifiers, and additives; agricultural chemicals; diagnostic films; and fine chemicals. Its Personal Care segment provides a range of natural, nature-derived, biodegradable, and performance ingredients; solutions for toothpastes, mouth washes and rinses, denture cleaning, and care for teeth; and household supplies nature-derived rheology ingredients, biodegradable surface wetting agents, performance encapsulates, and specialty polymers.
Headquarters: Wilmington, United States · 2,900 employees · ashland.com